$PTGX
Protagonist Therapeutics, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Newark, CA
PTGX chart
What traders are saying about $PTGX
Latest postsProtagonist Therapeutics, Inc news
- BlackRock amends its Protagonist Therapeutics (PTGX) stake disclosure, naming an iShares ETF with over 5%.
Stock Titan ·
- Protagonist Therapeutics to Participate in Four Investment Bank Conferences in November 2026
Yahoo Finance ·
- 10,448 Shares in Protagonist Therapeutics, Inc. $PTGX Purchased by Robeco Institutional Asset Management B.V.
MarketBeat ·
- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Stock Has Average Target Price of $158.19 According to Analysts
MarketBeat ·
- Protagonist Therapeutics, Inc. (PTGX) Stock Forecasts
Yahoo! Finance Canada ·
- Protagonist Therapeutics shifts to royalty mode...
Pluang ·
- Protagonist Therapeutics: The Opt-Out That Turned A Biotech Into A Royalty Compounder
Seeking Alpha ·
- Protagonist Therapeutics, Inc. Estimates – TRADEGATE:PGF
TradingView ·
- Protagonist Therapeutics, Inc. (PTGX) stock price, news, quote and history
Yahoo Finance Singapore ·
- J&J Stock Reclaims 50-Day SMA: Is it Time to Buy, Sell or Hold?
Yahoo Finance ·
- Protagonist Therapeutics (PTGX) Wins FDA Nod for MIMRYLO and a $275 Million Milestone
Simply Wall Street ·
- TD Cowen maintains Buy rating on Protagonist Therapeutics, $160 price target
TradingView ·
Protagonist Therapeutics, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$130.1M | $275.2M | -$79.0M | -$127.4M |
| Diluted EPS | $-2.05 | $4.23 | $-1.39 | $-2.60 |
| Total assets (year end) | $668.2M | $744.7M | $358.0M | $247.9M |
| Cash and equivalents (year end) | $128.4M | $97.2M | $186.7M | $125.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Protagonist Therapeutics, Inc
- Ticker
- PTGX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newark, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1377121
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
Frequently asked questions
What exchange is Protagonist Therapeutics, Inc listed on?
Protagonist Therapeutics, Inc trades on the Nasdaq under the ticker symbol PTGX.
What industry is Protagonist Therapeutics, Inc in?
Protagonist Therapeutics, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Protagonist Therapeutics, Inc headquartered?
Protagonist Therapeutics, Inc's business address on file with the SEC is in Newark, CA.
When does Protagonist Therapeutics, Inc's fiscal year end?
Protagonist Therapeutics, Inc's fiscal year ends on December 31.